Doris Kraemer - Concepedia

Author

Doris Kraemer

Also Known As

D Kraemer, D. Kraemer, D. M. Kraemer, D.M. Kraemer, DORIS KRAEMER, Doris Kraemer, Doris M Kraemer, Doris M. Kraemer, Doris Maria Kraemer, H-A Horst

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

Klinikum Oldenburg University of Würzburg Heinrich Heine University Düsseldorf Heidelberg University Charité - Universitätsmedizin Berlin

About

Doris Kraemer is an author at Klinikum Oldenburg specializing in medicine, hematology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	420
2	Cell Biology	6	6	120
3	Health Sciences	3	3	50
4	Natural Sciences	2	2	32
5	Biochemistry	2	2	32

Doris Kraemer

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Nup358, a Cytoplasmically Exposed Nucleoporin with Peptide Repeats, Ran-GTP Binding Sites, Zinc Fingers, a Cyclophilin A Homologous Domain, and a Leucine-rich Region Jian Wu, Michael J. Matunis, Doris Kraemer, Journal of Biological Chemistry	1995	481
Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITD Richard F. Schlenk, Daniela Weber, Walter Fiedler, Blood	2018	283
The human CAN protein, a putative oncogene productassociated with myeloid leukemogenesis, is a nuclear pore complex protein thatfaces the cytoplasm. Doris Kraemer, Richard W. Wozniak, Gerd A. Blobel, Proceedings of the National Academy of Sciences	1994	240
Impact of comorbidities on overall survival in patients with chronic myeloid leukemia: results of the randomized CML Study IV Susanne Saußele, Marie-Paloma Krauß, Rüdiger Hehlmann, Blood	2015	197
The Essential Yeast Nucleoporin NUP159 Is Located on the Cytoplasmic Side of the Nuclear Pore Complex and Serves in Karyopherin-mediated Binding of Transport Substrate Doris Kraemer, Caterina Strambio‐De‐Castillia, Günter Blobel, Journal of Biological Chemistry	1995	137
Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia—results of the AMLSG 11-08 trial Peter Paschka, Richard F. Schlenk, Daniela Weber, Leukemia Hematological MalignancyOncologyAmlsg 11-08 TrialImmunologyHematology	2018	104
mRNA binding protein mrnp 41 localizes to both nucleus and cytoplasm Doris Kraemer, Günter Blobel Proceedings of the National Academy of Sciences	1997	88
Human Deep Tissue Infection with an Entomopathogenic<i>Beauveria</i>Species Markus O. Henke, Sybren de Hoog, Gisbert Zimmermann, Journal of Clinical Microbiology	2002	56
Significant Improvement Of Outcome In Adolescents and Young adults (AYAs) Aged 15-35 Years With Acute Lymphoblastic Leukemia (ALL) With a Pediatric Derived Adult ALL Protocol; Results Of 1529 AYAs In 2 Consecutive Trials Of The German Multicenter Study Group For Adult ALL (GMALL) Nicola Gökbuget, Joachim Beck, Kalina Brandt, Blood	2013	52
Acute myeloid leukemia derived from lympho-myeloid clonal hematopoiesis Felicitas Thol, Sabrina Klesse, L Köhler, Leukemia Hematological MalignancyAcute Myeloid LeukemiaHematologyPathologyAutoimmunity	2016	52

Page 1